Nicodicosapent
N-[2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]ethyl]pyridine-3-carboxamide
Molecular Identity
Nicodicosapent
N-[2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]ethyl]pyridine-3-carboxamide
PubChem CID: 50991753
2D Structure
Properties
C28H39N3O2
Molecular Formula
449.60
Molecular Weight
g/mol
449.3042
Exact Mass
Da
5.7
XLogP
Above Lipinski threshold
71.1
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
3
H-Bond Acceptors
662
Complexity
SMILES
Canonical SMILES
SMILES: CCC=CCC=CCC=CCC=CCC=CCCCC(=O)NCCNC(=O)C1=CN=CC=C1Isomeric SMILES
SMILES: CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCNC(=O)C1=CN=CC=C1Synonyms(20)
Nicodicosapent1269181-69-2Nicodicosapent [INN]72995E50VAUNII-72995E50VAN-(2-((5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenamido)ethyl)pyridine-3-carboxamide3-Pyridinecarboxamide, N-(2-(((5Z,8Z,11Z,14Z,17Z)-1-oxo-5,8,11,14,17-eicosapentaen-1-yl)amino)ethyl)-nicodicosapentumRefChem:165711N-[2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]ethyl]pyridine-3-carboxamideCHEMBL3785912CAT-2054N-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenamido)ethyl)nicotinamideorb1706911SCHEMBL6518673
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Nicodicosapent
Loading drug network...